Inhibitor Therapeutics, Inc. (INTI) KPIs and segments
INTIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.11+0.00 (+0.09%)
Close on Oct 19, 2026Market cap $19.06MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Inhibitor Therapeutics's business
Coming soon
This tab will track the numbers specific to Inhibitor Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?